Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy

20 Feb 2023

Abstract excerpt

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric left ventricular hypertrophy. Currently, hypertrophy pathways responsible for HCM have not been fully elucidated. Their identification could serve as a nidus for the generation of novel therapeutics aimed at halting disease development or progression. Herein, we performed a comprehensive multi-omic characterization of hypertrophy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Fibrosis and Remodeling
Share to Cardiomyopathy and Myosin Studies
Share to Congenital heart defects research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36802768
DOI: 10.1161/circgen.122.003756

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-Omic Architecture of Obstructive Hypertrophic CardiomyopathyPMID 36802768Read ↗

A Multi-Omics Atlas of Sex-Specific Differences in Obstructive Hypertrophic CardiomyopathySemantic proximity Read ↗

Proteomic profiling identifies molecular subtypes and unveils mechanistic insights into clinical features of hypertrophic cardiomyopathy.Semantic proximity Read ↗

An 'Omics' Perspective on Cardiomyopathies and Heart Failure.Semantic proximity Read ↗

Proteomic Characterisation of Heart Failure Reveals a Unique Molecular Phenotype for Hypertrophic CardiomyopathySemantic proximity Read ↗

Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation-Contraction Coupling.Semantic proximity Read ↗

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy.Semantic proximity Read ↗

Proteogenomics of Hypertrophic Cardiomyopathy Reveals Subtype-Specific Therapy.Semantic proximity Read ↗

Single-cell transcriptomics provides insights into hypertrophic cardiomyopathySemantic proximity Read ↗

Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics.Semantic proximity Read ↗

Altered Intercellular Communication and Extracellular Matrix Signaling as a Potential Disease Mechanism in Human Hypertrophic CardiomyopathySemantic proximity Read ↗

Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic CardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.